Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study

References

• Botterweck AAM, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000 Aug;29(4):645–654.
   PubMed Web of Science ®Google Scholar
• Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013 Jan;23(1):3–9.
   PubMed Web of Science ®Google Scholar
• Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008 Nov;23(11):1662–1665.
   PubMed Web of Science ®Google Scholar
• Saito H, Fukumoto Y, Osaki T, et al. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg. 2006 Oct;30(10):1864–1869.
   PubMed Web of Science ®Google Scholar
• Xue L, Zhang X, Li Y, et al. Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach. Hum Pathol. 2011 Apr;42(4):594–601.
   PubMed Web of Science ®Google Scholar
• Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach [Clinical trial; Comparative study]. J Am Coll Surg. 1995;180(5):577–582.
   PubMed Web of Science ®Google Scholar
• Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998 Nov;85(11):1457–1459.
   PubMed Web of Science ®Google Scholar
• Hasegawa S, Yoshikawa T, Cho H, et al. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J Surg. 2009 Jan;33(1):95–103.
   PubMed Web of Science ®Google Scholar
• Curtis NJ, Noble F, Bailey IS, et al. The relevance of the siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. J Surg Oncol. 2014;109(3):202–207.
   PubMed Web of Science ®Google Scholar
• Steup WH, De Leyn P, Deneffe G, et al. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111(1):85–94. discussion 94-5.
   PubMed Web of Science ®Google Scholar
• Blank S, Lordick F, Dobritz M, et al. A reliable risk score for stage IV esophagogastric cancer. Eur J Surg Oncol. 2013 Aug;39(8):823–830.
   PubMed Web of Science ®Google Scholar
• Badgwell B, Roy-Chowdhuri S, Chiang YJ, et al. Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery. J Surg Oncol. 2015 Jun;111(7):875–881.
   PubMed Web of Science ®Google Scholar
• Liang W, Zhang L, Jiang G, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015 Mar 10;33(8):861–869.
   PubMed Web of Science ®Google Scholar
• Tang X, Zhou X, Li Y, et al. A novel nomogram and risk classification system predicting the cancer-specific survival of patients with initially diagnosed metastatic esophageal cancer: a SEER-based study. Ann Surg Oncol. 2019 Feb;26(2):321–328.
   PubMed Web of Science ®Google Scholar
• Yan Y, Liu H, Mao K, et al. Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma. J Transl Med. 2019 Jun 10;17(1):193.
   PubMedGoogle Scholar
• Zhou Z, Zhang H, Xu Z, et al. Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction. World J Surg Oncol. 2015 Jun;10(13):197.
   Google Scholar
• Liu F, Zhou R, Jiang F, et al. Proposal of a nomogram for predicting survival in patients with siewert type II adenocarcinoma of the esophagogastric junction after preoperative radiation. Ann Surg Oncol. 2019 May;26(5):1292–1300.
   PubMed Web of Science ®Google Scholar
• Miccio JA, Oladeru OT, Yang J, et al. Neoadjuvant vs. adjuvant treatment of siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry. J Gastrointest Oncol. 2016 Jun;7(3):403–410.
   PubMed Web of Science ®Google Scholar
• Zhu K, Xu Y, Fu J, et al. Proximal gastrectomy versus total gastrectomy for siewert type II adenocarcinoma of the esophagogastric junction: a comprehensive analysis of data from the SEER registry. Dis Markers. 2019;2019:9637972.
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008 Nov;26(8):53.
   Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006 Nov-Dec;26(6):565–574.
   PubMed Web of Science ®Google Scholar
• Di Lauro L, Giacinti L, Arena MG, et al. Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma. J Exp Clin Cancer Res. 2009 Mar;9(28):34.
   Google Scholar
• Rubenstein JH, Shaheen NJ. Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Gastroenterology. 2015 Aug;149(2):302–17 e1.
   PubMed Web of Science ®Google Scholar
• Dhupar R, Rice RD, Correa AM, et al. Endoscopic ultrasound estimates for tumor depth at the gastroesophageal junction are inaccurate: implications for the liberal use of endoscopic resection. Ann Thorac Surg. 2015 Nov;100(5):1812–1816.
   PubMed Web of Science ®Google Scholar
• Lee WC, Lee TH, Jang JY, et al. Staging accuracy of endoscopic ultrasound performed by nonexpert endosonographers in patients with resectable esophageal squamous cell carcinoma: is it possible? Dis Esophagus. 2015 Aug-Sep;28(6):574–578.
   PubMed Web of Science ®Google Scholar
• Lagarde SM, Ten Kate FJ, Reitsma JB, et al. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 2006 Sep 10;24(26):4347–4355.
   PubMed Web of Science ®Google Scholar
• Kulig P, Sierzega M, Pach R, et al. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location. Eur J Surg Oncol. 2016 Aug;42(8):1215–1221.
   PubMed Web of Science ®Google Scholar
• Lee JH, Chang KK, Yoon C, et al. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018 Jan;267(1):105–113.
   PubMed Web of Science ®Google Scholar
• Fornaro L, Fanotto V, Musettini G, et al. Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough. Future Oncol. 2017 Oct;13(25):2265–2275.
   PubMed Web of Science ®Google Scholar
• Carmona-Bayonas A, Jimenez-Fonseca P, Echavarria I, et al. Surgery for metastases for esophageal-gastric cancer in the real world: data from the AGAMENON national registry. Eur J Surg Oncol. 2018 Aug;44(8):1191–1198.
   PubMed Web of Science ®Google Scholar
• Riihimaki M, Hemminki A, Fallah M, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014 Oct;86(1):78–84.
   PubMed Web of Science ®Google Scholar
• Deng K, Yang C, Tan Q, et al. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients. Gynecol Oncol. 2018 Sep;150(3):460–465.
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180.
   PubMed Web of Science ®Google Scholar